Jin A Kim

Title: Jin A Kim: Innovator in Anticancer Pharmaceutical Composition

Introduction

Jin A Kim is a notable inventor based in Daegu, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compositions aimed at enhancing anticancer effects. His work focuses on addressing the challenges associated with liver cancer treatment.

Latest Patents

Jin A Kim holds 1 patent for his invention titled "Use of composition for enhancing anticancer effect, comprising ERRγ inhibitor as active ingredient." This innovative pharmaceutical composition is designed to inhibit the resistance of liver cancer to sorafenib, a common treatment, thereby enhancing its anticancer effect. The active ingredient in this composition is an Estrogen-related receptor γ (ERRγ) inhibitor, which has shown promise in treating sorafenib-resistant advanced liver cancer.

Career Highlights

Throughout his career, Jin A Kim has been associated with Novmetapharma Co., Ltd., where he has been instrumental in advancing research and development in cancer therapies. His expertise in pharmaceutical compositions has positioned him as a key figure in the fight against liver cancer.

Collaborations

Jin A Kim has collaborated with notable colleagues, including Keun Gyu Park and In Kyu Lee, to further enhance the impact of his research and innovations in the pharmaceutical field.

Conclusion

Jin A Kim's contributions to anticancer research highlight the importance of innovative pharmaceutical compositions in overcoming treatment resistance. His work continues to pave the way for advancements in cancer therapy, offering hope for patients facing challenging diagnoses.